Identification of MAD2L1 as a Potential Biomarker in Hepatocellular Carcinoma via Comprehensive Bioinformatics Analysis

BACKGROUND: Hepatocellular carcinoma (HCC) is widely acknowledged as a malignant tumor with rapid progression, high recurrence rate, and poor prognosis. At present, there is a paucity of reliable biomarkers at the clinical level to guide the management of HCC and improve patient outcomes. Our resear...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Qian, Yang, Sibo, Zhang, Yewei, Li, Bo, Xu, Huanming, Zuo, Shi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817109/
https://www.ncbi.nlm.nih.gov/pubmed/35132379
http://dx.doi.org/10.1155/2022/9868022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817109/
https://www.ncbi.nlm.nih.gov/pubmed/35132379
http://dx.doi.org/10.1155/2022/9868022

Ejemplares similares